BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 34298589)

  • 1. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts.
    Mohamed I; Kamarizan MFA; Da Silva A
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD002786. PubMed ID: 34298589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts.
    Tanner NC; Da Silva A
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD002786. PubMed ID: 26184395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts.
    Osborn G; Escofet X; Da Silva A
    Cochrane Database Syst Rev; 2008 Oct; (4):CD002786. PubMed ID: 18843633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.
    Bedenis R; Lethaby A; Maxwell H; Acosta S; Prins MH
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD000535. PubMed ID: 25695213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts.
    Da Silva AF; Escofet X; Rutherford PA
    Cochrane Database Syst Rev; 2003; (2):CD002786. PubMed ID: 12804437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease.
    Tam KW; Wu MY; Siddiqui FJ; Chan ES; Zhu Y; Jafar TH
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011353. PubMed ID: 30480758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical Adjuvant Treatment to Improve the Patency of Arteriovenous Fistulae and Grafts: A Systematic Review and Meta-analysis.
    Tanner NC; da Silva AF
    Eur J Vasc Endovasc Surg; 2016 Aug; 52(2):243-52. PubMed ID: 27289558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for preventing thrombosis in solid organ transplant recipients.
    Surianarayanan V; Hoather TJ; Tingle SJ; Thompson ER; Hanley J; Wilson CH
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD011557. PubMed ID: 33720396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet agents for the treatment of deep venous thrombosis.
    Flumignan CD; Nakano LC; Baptista-Silva JC; Flumignan RL
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012369. PubMed ID: 35876829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical Adjuvant Therapy in Reducing Thrombosis With Arteriovenous Grafts and Fistulae Use: A Meta-Analysis of Randomized Controlled Trials.
    Ullah K; Bashir M; Ain NU; Sarfraz A; Sarfraz Z; Sarfraz M; Cherrez-Ojeda I
    Clin Appl Thromb Hemost; 2021; 27():10760296211063882. PubMed ID: 34873965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery.
    Lewis SR; Pritchard MW; Schofield-Robinson OJ; Alderson P; Smith AF
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012584. PubMed ID: 30019463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet agents and anticoagulants for hypertension.
    Shantsila E; Kozieł-Siołkowska M; Lip GY
    Cochrane Database Syst Rev; 2022 Jul; 7():CD003186. PubMed ID: 35900898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentoxifylline for intermittent claudication.
    Broderick C; Forster R; Abdel-Hadi M; Salhiyyah K
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD005262. PubMed ID: 33063850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endovascular versus open repair of asymptomatic popliteal artery aneurysm.
    Joshi D; Gupta Y; Ganai B; Mortensen C
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD010149. PubMed ID: 31868929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment.
    Robertson L; Ghouri MA; Kovacs F
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002071. PubMed ID: 22895926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion techniques for peripheral arterial thrombolysis.
    Broderick C; Patel JV
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD000985. PubMed ID: 34786692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cilostazol for intermittent claudication.
    Brown T; Forster RB; Cleanthis M; Mikhailidis DP; Stansby G; Stewart M
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD003748. PubMed ID: 34192807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
    Perrotta C; Chahla J; Badariotti G; Ramos J
    Cochrane Database Syst Rev; 2020 May; 5(5):CD005259. PubMed ID: 32374919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasodilators for primary Raynaud's phenomenon.
    Su KY; Sharma M; Kim HJ; Kaganov E; Hughes I; Abdeen MH; Ng JHK
    Cochrane Database Syst Rev; 2021 May; 5(5):CD006687. PubMed ID: 33998674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.